BERLIN, April 8 (Reuters) - Germany's vaccine commission
stuck to its recommendation on Thursday that people aged under
60 who have received one shot of AstraZeneca's COVID-19
vaccine should receive an mRNA vaccine as their second dose.
The commission, known as STIKO, said the second dose should
be administered twelve weeks after the AstraZeneca shot.
Two mRNA vaccines, one from Pfizer/BioNTech
and one from Moderna, are currently approved
for use in Germany.
(Reporting by Caroline Copley, editing by Thomas Escritt)